# Outcome of COVID-19 Patients After Extracorporeal Membrane Oxygenation for Acute Respiratory Distress Syndrome

> **NCT04383678** · — · COMPLETED · sponsor: **Helsinki University Central Hospital** · enrollment: 132 (actual)

## Conditions studied

- COVID-19
- Extracorporeal Membrane Oxygenation Complication
- Acute Respiratory Distress Syndrome

## Interventions

- **DEVICE:** Extracorporeal membrane oxygenation

## Key facts

- **NCT ID:** NCT04383678
- **Lead sponsor:** Helsinki University Central Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-03-01
- **Primary completion:** 2021-04-01
- **Final completion:** 2021-04-01
- **Target enrollment:** 132 (ACTUAL)
- **Last updated:** 2021-04-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04383678

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04383678, "Outcome of COVID-19 Patients After Extracorporeal Membrane Oxygenation for Acute Respiratory Distress Syndrome". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04383678. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*